Pillstats
Rx only · Injection, Suspension · Intra-Articular

Betamethasone Sodium Phosphate And Betamethasone Acetate

Brands: Betaloan Suik · Betamethasone Acetate + Betamethasone Sodium Phosphate

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)1514
US makers3 labelers
Packages6
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$2.72$5.44$8.16$10.88Dec 2025Apr 2026Jul 2026
$9.402
Latest avg · Jul 22, 2026
+3%
Since Dec 17, 2025
3
Active US suppliers
83%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

28K57K85K114K2025 Q12025 Q22025 Q32025 Q42026 Q1
81K
Rx · 2026 Q1
177K
Units dispensed
-14%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
American Regent, Inc.unknown3SUPPLYING
Asclemed USA, Inc.unknown2SUPPLYING
ADVANCED RX PHARMACY OF TENNESSEE, LLCunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.